Valuation: Repligen Corporation

Market Cap 9.21B 7.98B 7.47B 6.82B 12.83B 878B 13.04B 87.6B 34.32B 440B 34.58B 33.82B 1,467B P/E 2026 *
216x
P/E 2027 * 94.3x
Enterprise Value 8.97B 7.78B 7.28B 6.64B 12.5B 856B 12.71B 85.38B 33.45B 428B 33.7B 32.96B 1,429B EV / Sales 2026 *
10.9x
EV / Sales 2027 * 9.08x
Free-Float
94.26%
Yield 2026 *
-
Yield 2027 * -
1 day+0.98%
1 week+12.04%
Current month+16.85%
1 month+14.23%
3 months+33.46%
6 months+15.18%
Current year+0.56%
1 week 149.94
Extreme 149.94
168.2
1 month 129
Extreme 129
168.2
Current year 100.99
Extreme 100.99
175.77
1 year 100.99
Extreme 100.99
175.77
3 years 100.99
Extreme 100.99
211.13
5 years 100.99
Extreme 100.99
327.32
10 years 26.16
Extreme 26.16
327.32
Manager TitleAgeSince
Chief Executive Officer 56 2024-08-31
Director of Finance/CFO 52 2023-09-24
Chief Tech/Sci/R&D Officer - 2025-07-31
Director TitleAgeSince
Chairman 74 2011-12-13
Director/Board Member 60 2014-06-11
Director/Board Member 67 2015-09-30
Date Insider Type Main position Quantity % Market Cap.
7/16/26 Sell

Chief Financial Officer

-530 0.0009%
6/25/26 Sell

Chief Financial Officer

-733 0.0013%
5/14/26 Free

Director

3,234 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
+0.98%+12.04%+47.87%-4.45% 9.21B
+1.01%+2.43%-18.29%+4.75% 188B
+1.42%+4.61%-2.37%+9.10% 114B
+2.73%+8.27%+17.09%+78.51% 62.02B
+2.38%+3.92%+35.52%+60.21% 55.26B
+0.99%+6.58%-6.25%-34.56% 48.93B
+2.14%+2.54%+13.53%-20.96% 33.08B
+3.64%-13.42% - - 29.66B
-0.22%+0.99%+45.81%-12.21% 24.78B
+8.53%+11.42%-5.85%+18.17% 23.91B
Average +2.36%+2,953.14%+14.12%+10.95% 58.92B
Weighted average by Cap. +1.85%+2,642.31%+1.59%+14.01%

Financials

2026 *2027 *
Net sales 827M 717M 671M 612M 1.15B 78.88B 1.17B 7.87B 3.08B 39.48B 3.11B 3.04B 132B 969M 840M 786M 717M 1.35B 92.44B 1.37B 9.22B 3.61B 46.27B 3.64B 3.56B 154B
Net income 41.92M 36.33M 34.01M 31.03M 58.4M 4B 59.38M 399M 156M 2B 157M 154M 6.68B 98.84M 85.66M 80.19M 73.17M 138M 9.43B 140M 940M 368M 4.72B 371M 363M 15.74B
Net Debt -234M -203M -190M -173M -326M -22.29B -331M -2.22B -871M -11.16B -877M -858M -37.22B -407M -353M -331M -302M -568M -38.86B -577M -3.88B -1.52B -19.45B -1.53B -1.5B -64.9B
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
2,000
Date Price Change Volume
26-08-11 US$164.77 +0.98% 989,268
26-08-10 US$163.17 -0.45% 770,770
26-08-07 US$163.90 +2.80% 950,498
26-08-06 US$159.44 +0.54% 1,221,255
26-08-05 US$158.59 +5.88% 1,281,864
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
164.77USD
Average target price
185.70USD
Spread / Average Target
+12.70%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RGEN Stock